Capital management is at the heart of value creation for insurance companies. It drives the capital productivity and cash generation that underpins dividends, growth, and strategic flexibility. Recognizing this, many insurers have worked hard in recent years to improve their capital-management practice by defining clear capital KPIs, embedding them in decision making, and building governance around them. Yet the maturity of this practice still varies widely. Some insurers steer capital with sophistication, while many others, though more advanced than a decade ago, still have considerable ground to cover.
For those at the less sophisticated end of the spectrum, the conversations with investors and analysts are becoming increasingly difficult. How insurers steer capital is being scrutinized more closely and systematically than ever. But even those with advanced capital-management capabilities are facing more probing questions from investors and analysts who want to know exactly how they are turning capital strength into value, thus raising the bar for capital management excellence. This article examines the capabilities that differentiate the leaders and how other insurers can close the gap and turn capital management into a durable source of value.
Sound Capital Management Builds Confidence
Some insurers, particularly those in the UK and the Netherlands, have been steering and reporting on capital generation and cash remittance for years. Others have reported on capital management largely in terms of solvency requirements and considered cash, returns, and growth as separate and distinct performance criteria. But today, with solvency ratios uniformly strong and capital generation robust across major European insurers, the questions from investors and analysts have become more pointed.
For example: How stable and sustainable is reported capital generation, or is it flattered by one-off effects and favorable markets? How does capital generation convert into cash at the holding company? How will the company deploy excess capital across dividends, buybacks, organic growth, and M&A, and why is that allocation the best choice? As one analyst put it, “Solvency is not the issue for any of these names. The question is what the capital is actually worth.”
These questions were not entirely absent in the past, but they are now asked more consistently and precisely. And the capital test is harder than it was in the past. When an insurer can clearly demonstrate how its capital converts into cash, returns, and growth, it builds confidence; when an insurer cannot, questions mount and valuations can suffer—even when the headline solvency ratio and capital generation look strong. One analyst told us, “What matters now isn’t the surplus, it’s what they can actually do with it.”
Two developments may raise the bar even higher for capital management excellence. The Solvency II Review, which will take effect in early 2027, is likely to lift solvency coverage ratios for many European insurers, creating a timely opportunity for CFOs to reassess capital allocation and revisit decisions. But additional headroom does not automatically translate into capital that can be put to work. Local statutory and accounting constraints, fungibility, and management buffers will determine how much ultimately becomes available for redeployment. The impact will differ across insurers, depending on business mix, asset allocation, and balance sheet characteristics.
At the same time, higher interest rates, while supporting coverage ratios, have left unrealized losses on many local balance sheets. This could constrain the conversion of reported capital strength into distributable cash. The distinction is critical: one euro of additional regulatory headroom is not necessarily one euro available for redeployment. The management challenge is to determine how much capital can actually be converted into deployable resources and where those resources create the most value. For insurers that get this right, the coming years offer a window to pull ahead.
What Best in Class Looks Like
An insurer’s progression toward capital management excellence begins with a focus on regulatory compliance and advances to managing capital, integrating KPIs, and, ultimately, optimizing value. (See Exhibit 1.) In the final stage, capital is no longer simply monitored but actively steered toward its highest-value use.
We have found that an insurer’s capital management expertise depends on three elements: its steering framework, analytical capabilities, and optimization levers.
Steering Framework. Defining the capital steering framework is a board-level responsibility that cuts across finance, risk, actuarial, investments, and the business. It has six key elements. (See Exhibit 2.)
At the start of the framework are capital steering KPIs (such as measures for capital generation, cash generation, and solvency) chosen based on the company’s purpose, strategy, and financial objectives. This is why leading exhange-listed insurers and mutual insurers typically steer by different metrics, with the former leaning toward shareholder value measures and the latter toward policyholder value, resilience, and long-term surplus.
Crucially, management connects KPIs—to one another and to the group’s other performance measures—so that it’s clear to stakeholders how operating decisions influence group capital. Management then cascades the decisioning logic consistently from the group level down to business units and legal entities. The most sophisticated carry this logic through to the individual business lines.
Leading insurers deeply embed this steering framework in their operating model. They define and align on tradeoffs (such as how growth is weighed against capital return and how cash is weighed against capital generation) to avoid debating these tradeoffs every time a decision must be made. All this helps these companies direct capital toward their highest risk-adjusted use for growth, balance sheet investment, M&A, and, if applicable, shareholder distributions.
Leading insurers then hardwire these choices into planning, budgeting, and incentives, with clear accountability for outcomes. These insurers also regularly challenge whether solvency targets and management buffers remain economically justified. It is this combination—a well-designed framework that is consistently cascaded, embedded, and acted upon—that turns capital management from a reporting exercise into a steering discipline.
Analytical Capabilities. Many insurers don’t know how their business plan will impact capital until after the plan is set in motion. Moreover, they have limited ability to drill down into business lines, risk types, or drivers. This constraint impedes the optimal steering of capital and cash generation, leaving value on the table.
Leading insurers are investing significantly in analytics to improve financial and capital steering. These capabilities include accessing near-real-time information to monitor capital and financial KPIs against the business plan and forecast (at group, local, and portfolio levels); automatically creating a dashboard with AI-supported root-cause analysis that reveals where performance is diverging and how to respond; and rapidly assessing what-if scenarios and generating answers in minutes rather than weeks.
The effect is that capital analysis is no longer a backward-looking report but a forward-looking input for business decisions. AI is the key enabler of this shift, particularly when combined with faster modeling, better data, and greater automation. Together, these capabilities bring the capital, cash, earnings, and solvency implications into the management dialogue earlier, sharpening decisions and compounding into greater value creation over time. (See Exhibit 3.)
Optimization Levers. Leading insurers do not just measure and steer capital, they also invest massively in their optimization capabilities. In the past two to three years, leaders have built up even more skills to optimize capital. With these stepped-up capabilities, they are standing up dedicated teams, deepening actuarial and asset-modeling talent, and giving capital optimization focused management attention. As a result, instead of pulling one lever at time, these insurers are applying several at once.
We have identified well over a hundred distinct levers spanning product and business mix, assets and asset-liability management (ALM), reinsurance, models and assumptions, legal-entity capital and fungibility, treasury and capital structure, and portfolio actions. (See Exhibit 4.) Many insurers have already shown that using multiple levers simultaneously creates substantial impact. For example, a global top-ten insurer identified and upstreamed €4 billion of capital from business units, while a medium-sized European monoliner increased bottom-line capital generation by €300 million per year.
There are two dimensions to optimization excellence. The first is the depth in each individual lever. A sophisticated strategic asset allocation or a well-structured reinsurance solution creates value and an advantage over peers. The allocation also optimizes risk-adjusted value to improve resiliency across several areas, including solvency, liquidity, and management’s ability to respond under adverse scenarios.
The second dimension is breadth and the ability to expertly combine levers based on how they interact. For example, by using internal reinsurance, an insurer can free up capital at a local business unit for reinvestment into growth or a riskier asset allocation to lift future capital generation. Or, by switching from reserves or models that are overly conservative, a company can raise solvency and reinvest in higher-returning assets. Still further, by allocating a larger market-risk budget, an insurer can lift investment returns while consuming solvency headroom. By quantifying the interaction of the levers across capital, cash, earnings, and risk, leading insurers can choose the combination that best serves their objectives. To demonstrate, consider two of these levers: strategic asset allocation and internal and external reinsurance.
Strategic Asset Allocation. At many insurers, the strategic asset allocation (SAA) lever is constrained by analytical, process, data, and model-runtime issues. The typical process uses economic assumptions, optimizes the SAA against the existing risk appetite using proxy metrics, narrows the SAA down to a handful of candidate portfolios, and then uses capital models to evaluate the risk profile of those few candidates. The outcome is an SAA that leaves significant profit potential on the table.
Leading insurers have broken with this approach. By establishing a genuine link between their capital, actuarial, and asset models, these insurers can see how market risk, minimum solvency, liquidity, duration and ALM constraints, asset-class limits, and local accounting requirements shape expected return. Then through rapid real-time sensitivity analysis, they can see how tightening or relaxing any one model moves the risk-return-solvency profile. (See Exhibit 5.)
The experience in the ALM or investment committee is thus transformed. Rather than reviewing a static set of precomputed options, management explores tradeoffs live and decides on the spot. We’ve worked with European insurers that have lifted risk-adjusted investment returns by 30 basis points or more. Depending on balance sheet size, this can translate into tens or even hundreds of millions of euros of additional annual earnings.
Internal and External Reinsurance. On the reinsurance front, much has changed in recent years. What was once largely a proportional risk transfer between entities has become a deliberate capital instrument that releases solvency and reserve capital, transfers asset and market risk, and steers cash and earnings across the group. In life and health insurance in particular, asset-intensive and ALM reinsurance levers can now transfer long-duration liabilities with select interest rate, credit spread, currency, inflation, or biometric risks. Assets often remain with the cedent while the associated economics and risk pass to the reinsurer.
Realizing this potential is itself a capability. Leading insurers invest in dedicated internal reinsurance teams and governance to screen portfolios systematically, compare internal and external structures, and quantify implications across capital, cash, accounting, and risk. They then select the structure best aligned with their objective. The approach turns reinsurance from a periodic risk-transfer decision into a continuously managed lever of capital strategy.
A Strategic Agenda for CFOs
The link between capital management and value is direct. Insurers that can convert capital strength into cash, growth, and distributions—and can show how—will be rewarded, while those that cannot will face pressure on their valuations. That makes building this capability a strategic priority, not a technical one. Here are five questions CFOs should ask:
- How do we compare? Benchmarking against peers on the metrics that matter (capital generation, cash conversion, capital productivity, and distributions) helps determine where the group stands and how sustainable performance is. This outside-in view establishes both the gap between the company and its best-in-class competitors and the size of the prize.
- How much of our capital is truly deployable? Headline solvency tells only part of the story. The question is: How much capital can move across legal entities, be converted into cash, and be put to work at the group level? In addition, what constraints are preventing that conversion?
- Where is capital creating the most value? Leading insurers understand not only where capital is generated and consumed but also the returns it earns across businesses, products, and risks.
- Are we using the full optimization potential? A strong or weak position is rarely explained by one factor. The task is to identify where value is being lost and whether the full set of levers is being used individually and in combination.
- Where should the next euro of capital go? With the economics and constraints understood, management can explicitly direct capital toward the uses that best serve the group’s strategic and financial objectives (such as organic growth, balance sheet investment, M&A, and shareholder distributions).
The progression of capital management from regulatory compliance to optimized value is not about adding more metrics or optimization levers. It is about moving from knowing how much capital the group has to understanding how its capital moves, what returns it earns, and where to deploy it. It is a discipline that insurers need to master as soon as possible, because after it is in place, it still takes time to assess opportunities, prioritize actions, and implement solutions before the benefits of capital management materialize.
Adding to the internal pressures to create value are the external demands of investors and analysts. Insurers need to develop a credible equity story and clearly articulate how their capital-management strategy will translate into sustainable capital generation, cash, and stakeholder value. The insurers that treat capital management as an integrated capability—and build it deliberately—will turn capital strength into lasting value.